$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
前列腺癌只吃比卡鲁胺片行吗?比卡鲁胺片什么时候吃最好?
2025-10-19 11:44:20
Check Details
比卡鲁胺片吃多久停药?比卡鲁胺片停药标准是什么?
2025-10-19 11:44:20
Check Details
【2021年医保政策】朝晖先比卡鲁胺片医保报销吗?医保报销比例是多少?
2025-10-19 11:44:20
Check Details
FDA批准PYLARIFY用于前列腺癌的PSMA PET检测
2025-10-19 11:44:20
Check Details
【靶向药用药咨询】比卡鲁胺是进口药吗?比卡鲁胺吃多久见效?
2025-10-19 11:44:20
Check Details
比卡鲁胺和阿比特龙哪个好,比卡鲁胺必须长期服用吗?
2025-10-19 11:44:20
Check Details
晚期前列腺癌,吃比卡鲁胺能延长几年寿命?
2025-10-19 11:44:20
Check Details
比卡鲁胺2021最新价格,比卡鲁胺现在多少钱?
2025-10-19 11:44:20
Check Details
朝晖先(比卡鲁胺片)2021最新说明书,朝晖先(比卡鲁胺片)的作用和功效
2025-10-19 11:44:20
Check Details
朝晖先(比卡鲁胺片)哪里能买到?朝晖先(比卡鲁胺片)在线购买
2025-10-19 11:44:20
Check Details
朝晖先(比卡鲁胺片)可以治疗什么癌症?朝晖先(比卡鲁胺片)的疗效如何?
2025-10-19 11:44:20
Check Details
进口比卡鲁胺与国产比卡鲁胺哪个好?比卡鲁胺片国产与进口的区别
2025-10-19 11:44:20
Check Details
1
2
...
1550
1551
1552
1553
1554
1555
1556
...
4161
4162
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Pemigatinib for FGFR2 Cholangiocarcinoma and FGFR1 Hematologic Use: First-Line Data, 21-Day Dosing, Phosphate and Ocular Management
2
Dabrafenib (Tafinlar) Complete Guide: Indications, Dosing, Combination Therapy and Safety
3
Binimetinib plus Encorafenib for BRAF‑Mutant Melanoma
4
Adagrasib (Krazati) for KRAS G12C: NSCLC Dosing, Titration, and CRC Regulatory Update
5
Ceritinib for ALK-Positive NSCLC: Indication, Dosing, and Safety Management
6
Enzalutamide for Prostate Cancer: Managing Fatigue, Dizziness, Hypertension, and Serious Neurocardiovascular Risks
7
Tamoxifen Long-Term Safety: Vigilance for Thrombosis and Endometrial Risks
8
Acoramidis for ATTR-CM: Disease Progression Is Not Equivalent to Drug Resistance
9
Lorlatinib Contraindications and Safety Warnings: Six Key Risks to Monitor
10
Dacomitinib for EGFR-Mutant NSCLC: Dosing, Switching, and Safety Profile
11
Abemaciclib for HR+ HER2- Breast Cancer: Mechanism, Combination Therapy, and Switching Considerations
12
Cemiplimab Mechanism of Action: How PD-1 Inhibition Restores Antitumor Immunity